Article

Bio-tests for Schizophrenia And Depression

The race to patent bio-tests for schizophrenia and depression: some say this initiative is destined to fail.

Recent articles by Arline Kaplan and Hagop Asiskal, MD, highlight the race to patent bio-tests for schizophrenia and depression. Dr Max Fink continues the discussion in his commentary; he contends the DSM divisions serve patients and doctors poorly. Tell us what you think.
 

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
depression
brain depression
nicotine use
brain schizophrenia
brain
schizophrenia
depression obesity
© 2024 MJH Life Sciences

All rights reserved.